MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Surmodics P/B Ratio 2011-2026 | SRDX
Annual P/B Ratio Surmodics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.66 | 4.01 | 4.67 | 4.41 | 5.38 | 5.13 | 7.72 | 3.46 | 3.05 | 3.02 | 2.98 | 3.74 | 3.52 | 1.31 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.72 | 1.31 | 4.08 |
P/B Ratio of other stocks in the Diagnostics research industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
7.78 | $ 113.86 | -0.84 % | $ 34.6 B |  USA |
 |
CareDx, Inc
CDNA
|
3.28 | $ 17.54 | -1.6 % | $ 935 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
1.79 | $ 189.99 | -1.09 % | $ 135 B | USA |
 |
DexCom
DXCM
|
9.29 | $ 63.27 | 0.09 % | $ 24.7 B | USA |
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
1.22 | $ 16.3 | -0.03 % | $ 175 M |  China |
 |
Co-Diagnostics
CODX
|
0.284 | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
2.4 | $ 168.38 | 0.1 % | $ 8.35 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | USA |
 |
Castle Biosciences
CSTL
|
1.56 | $ 24.8 | 0.26 % | $ 689 M | USA |
 |
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | USA |
|
Biodesix
BDSX
|
4.41 | $ 14.68 | -4.46 % | $ 1.9 B | USA |
 |
Fulgent Genetics
FLGT
|
0.413 | $ 16.14 | -1.71 % | $ 488 M | USA |
 |
Guardant Health
GH
|
-135 | $ 90.77 | 1.23 % | $ 11.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
1.74 | $ 108.32 | -1.19 % | $ 8.93 B |  Irlanda |
 |
Illumina
ILMN
|
2.6 | $ 126.53 | -0.95 % | $ 20.1 B | USA |
 |
Anixa Biosciences
ANIX
|
0.00742 | $ 2.66 | 2.7 % | $ 86.3 K | USA |
 |
Biomerica
BMRA
|
1.75 | $ 2.13 | -1.84 % | $ 4.89 M | USA |
 |
BioNano Genomics
BNGO
|
0.179 | $ 1.15 | -0.43 % | $ 6.26 M | USA |
 |
Interpace Biosciences
IDXG
|
0.328 | $ 1.99 | 1.02 % | $ 8.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
2.77 | $ 271.64 | -1.06 % | $ 22.6 B | USA |
 |
Lantheus Holdings
LNTH
|
4.7 | $ 76.57 | 0.89 % | $ 5.17 B | USA |
 |
Celcuity
CELC
|
53.4 | $ 114.53 | 0.27 % | $ 5.36 B | USA |
 |
Medpace Holdings
MEDP
|
28.2 | $ 502.01 | 1.21 % | $ 14.5 B | USA |
 |
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | USA |
 |
Myriad Genetics
MYGN
|
1.11 | $ 4.64 | -0.64 % | $ 430 M | USA |
 |
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
1.77 | $ 7.94 | -1.0 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
0.492 | $ 9.94 | 3.97 % | $ 2.16 B | USA |
 |
Exact Sciences Corporation
EXAS
|
8.12 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
22.5 | $ 17.11 | -1.3 % | $ 383 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 197.89 | -0.58 % | $ 22 B | USA |
 |
Natera
NTRA
|
7.52 | $ 207.28 | 1.18 % | $ 20.4 B | USA |
 |
ENDRA Life Sciences
NDRA
|
1.62 | $ 4.8 | 1.27 % | $ 3.78 M | USA |
 |
Pacific Biosciences of California
PACB
|
93.1 | $ 1.45 | 1.76 % | $ 435 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
0.995 | $ 26.86 | -1.3 % | $ 20 B | Niderland |
 |
Precipio
PRPO
|
2.63 | $ 26.45 | 1.79 % | $ 42.5 M | USA |
 |
Personalis
PSNL
|
1.25 | $ 6.11 | -7.22 % | $ 362 M | USA |
 |
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | USA |